Cannabics Pharmaceuticals Inc. (CNBX) SEC Filing 8-K Material Event for the period ending Monday, October 7, 2019

SEC Filings

Cannabics Pharmaceuticals Inc.

CIK: 1343009 Ticker: CNBX

View differences made from one to another to evaluate Cannabics Pharmaceuticals Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Cannabics Pharmaceuticals Inc..


Assess how Cannabics Pharmaceuticals Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Cannabics Pharmaceuticals Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors



Material Contracts, Statements, Certifications & more

Cannabics Pharmaceuticals Inc. provided additional information to their SEC Filing as exhibits

Ticker: CNBX
CIK: 1343009
Form Type: 8-K Corporate News
Accession Number: 0001683168-19-003192
Submitted to the SEC: Mon Oct 07 2019 10:00:17 AM EST
Accepted by the SEC: Mon Oct 07 2019
Period: Monday, October 7, 2019
Industry: Pharmaceutical Preparations
  1. Event for Officers
  2. Financial Exhibit

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: